Exelixis
EXEL
#1458
Rank
A$21.22 B
Marketcap
A$85.67
Share price
1.42%
Change (1 day)
45.38%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): A$1.52 Billion

According to Exelixis's latest financial reports the company's current earnings are A$2.43 Billion. In 2025 the company made an earning of A$1.34 Billion, an increase over its 2024 earnings that were of A$0.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.52 B13.28%
2025 A$1.34 B38.08%
2024 A$0.97 B164.69%
2023 A$0.36 B9.89%
2022 A$0.33 B-20.33%
2021 A$0.42 B124.82%
2020 A$0.18 B-67.14%
2019 A$0.56 B-11.94%
2018 A$0.64 B185.09%
2017 A$0.22 B-325.82%
2016 -A$0.11 Billion-58.12%
2015 -A$0.24 Billion-37.61%
2014 -A$0.39 Billion9.75%
2013 -A$0.36 Billion65.96%
2012 -A$0.22 Billion-291.63%
2011 A$0.11 B-195.59%
2010 -A$0.12 Billion-42.17%
2009 -A$0.2 Billion-18.98%
2008 -A$0.25 Billion-6.99%
2007 -A$0.27 Billion46.3%
2006 -A$0.19 Billion33.25%
2005 -A$0.14 Billion-30.92%
2004 -A$0.2 Billion44.29%
2003 -A$0.14 Billion12.86%
2002 -A$0.13 Billion22.79%
2001 -A$98.24 Million60.14%
2000 -A$61.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B 2,431.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.88 B 567.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.72 B 893.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.24 B 591.50%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$11.00 B 642.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.04 B 1,050.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$11.29 B 661.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-A$12.09 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-A$41.56 Million-102.80%๐Ÿ‡บ๐Ÿ‡ธ USA